MedTrace Logo

Hormone Replacement Therapy and Prothrombotic Variants

NCT00049933 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2018-05-07

No results posted yet for this study

Summary

To examine in postmenopausal women the potential interactions of hormone replacement therapy with other blood clotting factors on the risk of cardiovascular diseases such as heart attack or stroke.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Bruce Psaty · University of Washington

Eligibility

Min Age
30 Years
Max Age
79 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-09-30
Primary Completion
2008-08-31
Completion
2008-08-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00049933 on ClinicalTrials.gov